Diagnosing and managing pediatric diabetes
Primary care providers and pediatricians play an invaluable role in the diagnosis of diabetes mellitus and timely interventions. “Diagnosing diabetes mellitus often starts with pediatricians or other primary care providers when parents bring in their […]
View more
January 2024 Norton Children’s Medical Group New Providers
Mary E. Dedman, M.D. Pediatrics Thomas E. McCormick, M.D. Pediatrics Leigh A. Nieto, M.D. Pediatrics Lorraine A. Rust-Killeen, M.D. Pediatrics Kerby D. Albert, APRN Neonatology Amy M. Barry, APRN Neonatology Emily A. Hickerson, […]
View more
Staying at the forefront of insulin administration capabilities and glucose monitoring
Insulin administration has advanced well beyond the “old school” delivery with a vial and syringe. Patients with Type 1 and Type 2 diabetes mellitus cared for at Wendy Novak Diabetes Institute, a part of Norton Children’s [...]
View more
December 2023 Norton Children’s Medical Group New Providers
Jennifer O. Hockenbury, M.D. Pediatric Emergency Medicine Angela M. Jeffries, M.D. Pediatric Gastroenterology Benjamin H. Lyvers, M.D. Pediatric Emergency Medicine Ivory J. Shelton, M.D. Pediatric Emergency Medicine Leena Mohapatra, Ph.D. Pediatric Neurosurgery Jennifer […]
View more
September 2023 Norton Children’s Medical Group New Providers
Rachel L. Evans, M.D. Pediatric Neurology Stephanie M. Green, D.O. Pediatric Physical Medicine and Rehabilitation Kelly A. Jenkins, M.D. Pediatric Orthopedic Surgery Michael S. Orangias, M.D. Pediatric Pulmonology, Pediatric Sleep Medicine Huma […]
View more
November 2023 Norton Children’s Medical Group New Providers
Christie Buonpane, M.D. Pediatric General Surgery Claire E. Milligan, Ph.D. Pediatric Psychology Kathryn R. Gallegos, APRN Pediatric Neurology Austin Peters, APRN Pediatrics Corinne M. Streble, APRN Pediatric Cardiology
View more
Tzield may delay Stage 3 Type 1 diabetes in adults and children
Recently approved Tzield (teplizumab-mzwv), is delivering breakthrough results that suggest it may delay the onset of Stage 3 Type 1 diabetes by an average of two years. The first-in-class drug is approved for adults and […]
View more
Ultra-fast-acting inhaled insulin, Afrezza, trialed at Norton Children’s Endocrinology
Afrezza inhaled insulin, currently approved for adults, is being tested for children in a clinical trial at Wendy Novak Diabetes Institute, a part of Norton Children’s Endocrinology, affiliated with the UofL School of Medicine. Norton […]
View more
DFMO medulloblastoma clinical trial examines drug’s effectiveness for high-risk cases
Researchers are recruiting pediatric medulloblastoma patients for a novel use of difluoromethylornithine (DFMO) to prevent relapse. The multisite study, sponsored by the Beat Childhood Cancer Consortium and led by Michael Angelo C. Huang, M.D., pediatric [...]
View more
Norwood vs. COMPSII for critical left heart obstruction with prior palliation
Surgeons face two choices for infants with critical left heart obstruction who have had prior hybrid palliation: a Norwood operation or a comprehensive stage II (COMPSII). The critical left heart obstruction cohort of the multi-institutional […]
View more
October 2023 Norton Children’s Medical Group New Providers
Rachel L. Evans, M.D. Pediatric Neurology Stephanie M. Green, D.O. Pediatric Physical Medicine and Rehabilitation Kelly A. Jenkins, M.D. Pediatric Orthopedic Surgery Michael S. Orangias, M.D. Pediatric Pulmonology, Pediatric Sleep Medicine Huma […]
View more
Thyroid weight gain myths and surprises
Patients often suspect a thyroid condition is responsible for their weight gain or their weight loss struggles. Much of the stimulus for this belief is based on the internet, according to Lisal J. Folsom, M.D., […]
View more